Aviva’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-24,885
| Closed | -$1.23M | – | 899 |
|
|
2021
Q1 | $1.23M | Sell |
24,885
-3,392
| -12% | -$167K | 0.01% | 806 |
|
|
2020
Q4 | $1.19M | Sell |
28,277
-22,924
| -45% | -$965K | 0.01% | 836 |
|
|
2020
Q3 | $2.34M | Buy |
51,201
+4,631
| +10% | +$212K | 0.01% | 658 |
|
|
2020
Q2 | $2.34M | Sell |
46,570
-28,464
| -38% | -$1.43M | 0.01% | 625 |
|
|
2020
Q1 | $3.86M | Buy |
75,034
+44,451
| +145% | +$2.29M | 0.03% | 479 |
|
|
2019
Q4 | $1.89M | Buy |
+30,583
| New | +$1.89M | 0.01% | 781 |
|